Feedback / Questions
NT-0796 - NodThera
https://www.globenewswire.com/fr/news-release/2025/06/04/3093418/0/en/NodThera-Charts-Obesity-Future-with-First-Patients-Dosed-in-Phase-2-RESOLVE-1-Trial-of-Oral-NLRP3-Inflammasome-Inhibitor-NT-0796.html
Jun 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next